Abstract
Objective: To evaluate the quality of life of the patient with Chronic Myeloid Leukemia (CML) submitted to oral chemotherapy. Methods: Quantitative research was used to collect data from the application of two instruments: socio-demographic, clinical and therapeutic data; and the World Health Organization Quality of Life (WHOQOL-bref) questionnaire to assess quality of life. The sample consisted of 105 patients seen at the chemotherapy outpatient clinic of a hospital in João Pessoa-PB, from September 2015 to September 2016. Results: It was evidenced the prevalence of males and the mean age of the patients was 31 to 40 years. According to the results found, it can be verified that the physical and psychological domains were the most affected, with a statistically significant difference for the physical domain in relation to all the domains. It is seen that hematologic neoplasia causes changes in the patient's life, demonstrating that adverse reactions to treatment negatively influence their quality of life. Conclusion: Therefore, it is necessary to take care of the health professionals in the impact that the treatment causes in this process of the patient with CML, taking into account the domains of quality of life affected.